News | April 18, 2013

Two Venous Punctures Not Needed for Intravascular Ultrasound-Guided IVC Filter Placement

Study shows success of the single puncture

Angiotech Vena Cava Filter

April 18, 2013 — One venous puncture, rather than two, is a safe and effective approach to intravascular ultrasound-guided inferior vena cava filter placement in critically-ill patients according to a new study shows. Inferior vena cava filter placement is done to prevent or treat pulmonary emboli or deep venous thrombosis.

"The majority of institutions use a dual venous puncture technique, while we use a single venous puncture technique," said Andrew Gunn, M.D., of Massachusetts General Hospital in Boston. "We were interested to know if the different approaches affected technical success, clinical success or the rate of complications with the procedure.”

In a study of 99 patients, the single puncture technique was technically successful in almost 94 percent of cases, which is comparable to the dual puncture approach. The rate for deep venous thrombosis at the venous access site was 2 percent. This compares to approximately 4 percent with the double puncture approach.

Gunn noted that contrast venography is the most common method employed for guiding inferior vena cava filter placement; however, intravascular ultrasound-guided placement is particularly useful in treating critically ill patients, patients who have contrast allergies as well as those who have compromised renal function.

"Intravascular ultrasound-guided placement can be done at the patient's bedside, eliminating the need for time-consuming and often difficult patient transport,” he said. About 41% of the inferior vena cava filter placements were done at the bedside.

"The filter was slightly more likely to be malpositioned if the procedure was done at the patient's bedside," Gunn said.

For more information: www.arrs.org

Related Content

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
Sponsored Content | Videos | Venous Therapies| June 27, 2017
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein th
New Data Demonstrate Clinical and Quality-of-Life Benefits for VenaSeal Closure System in Venous Reflux Disease Patients
News | Venous Therapies| May 05, 2017
Medtronic plc recently announced three-year outcomes from the VeClose U.S. pivotal clinical trial and one-year data...
Conavi Medical Receives FDA Clearance for Feature Expansion on Foresight Intracardiac Echocardiography System
Technology | Ultrasound Intra-cardiac Echo (ICE)| May 01, 2017
Conavi Medical Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Foresight ICE (...
News | Venous Therapies| April 26, 2017
A new Varicose Vein Registry has begun producing useful outcomes information, as reported in the May edition of the...
News | Venous Therapies| September 12, 2016
Veniti Inc. has closed on $25 million in Series D equity financing from Boston Scientific Corp. The funds will allow...
Koven Technology, Smartdop XT vascular testing system,
Technology | Cardiac Diagnostics| March 30, 2016
The Smartdop XT by Koven is a fully automated vascular testing system that enables rapid, multiple-level bilateral...
Overlay Init